About Us

Overview

KBL Healthcare Acquisition Corp. III (“KBL”) is a specified purpose acquisition company (“SPAC”), a newly organized black check company established for the purpose of effecting a merger, capital stock exchange, stock purchase, asset acquisition or other similar business combination with one or more operating businesses in the healthcare or healthcare-related industries in any geographic location.

In July 2007, KBL completed a $138 million IPO led by Citi to target a merger with a healthcare or healthcare-related business.

• KBL is seeking a merger with a company valued between $110 and $500+ million
  

• The merged company will become a publicly traded company
  
• KBL can provide management and shareholders with:
  
  

• Significant and immediate liquidity to management and shareholders
• Significant upside potential through ownership and earn-outs
• Growth capital to build business and make strategic acquisitions
  
  
• KBL has a strong track record in healthcare:
  
  
  • Decades of successful healthcare investing experience
  • Significant M&A transaction and capital raising experience
  • Wide network of healthcare and venture capital industry relationships
  • World class Board and Advisors
    
    
• KBL has a strong track record in SPACs:
  
  
  • Successfully closed two SPAC transactions, raised three SPAC IPOs
  • KBL Healthcare Acquisition Corp. I: $17.3mm IPO in April 1993
  • KBL Healthcare Acquisition Corp. II / Summer Infant: $55.2mm IPO in April 2005
  • KBL Healthcare Acquisition Corp. III: $138mm IPO in July 2007
  • KBL III is Citi’s first healthcare SPAC

Our common stock, units and warrants are traded on the American Stock Exchange under the symbols “KHA”, “KHA-U” and “KHA.WT”, respectively.